MrT

John Strickler, MD, and team's milestone work on the clinical trial "MOUNTAINEER" has led to the first FDA-approved treatment regimen for HER2+ metastatic colorectal cancer.

Learn how the Precision Cancer Medicine Initiative is advancing research, extending lives, and breaking down barriers to access.

There's nothing like cancer, many survivors say, to remind you that nothing is guaranteed. Good or bad. Renee Garber got an unexpected "bonus year."

For some patients, targeted therapy is their best shot. The Molecular Tumor Board at DCI is matching more and more patients to approved therapies and clinical trials.

DCI was invited to join the elite international AACR Project GENIE consortium, whose registry contains clinical-grade cancer genomic sequencing data from nearly 71,000 patients & 80 major cancer types.